What is Glioblastoma (GBM)?
Glioblastoma (GBM) is the most diagnosed and deadliest brain tumour in adults.
Currently, there is no known cure.
​
DID YOU KNOW? Glioblastoma kills more children in Australia than any other disease and more people under the age of 40 than any other cancer. Over the last decade, an average of 1,800 Australians were diagnosed with brain cancer every year.
240,000
people diagnosed globally with GBM.
​
​
95 Percent
people diagnosed die within five years with more than half having a median life span of 15 months.
30 Years
There have been limited new treatment options in over 30 years.
​
45 Percent
of malignant brain tumours are glioblastoma.
​
​
Challenges in Diagnosis and Treatment
The standard clinical trial model hinders delivering better glioblastoma treatments. It takes more than eight years, costs millions, yet offers no cure.
Other challenges include:
-
Proliferation
-
Blood-brain barriers
-
Chemoresistance
-
Varying symptoms depending on the tumour location in the brain
-
Grows and spreads rapidly
-
Invasion
​
But we are changing the way we fight brain cancer with the NEW GBM AGILE trial.
This is a difficult and highly unpredictable cancer.
– Matthew McCarron
Be the Difference
There is a desperate need for more research to understand how GBM develops and resists treatments. GBM AGILE will help get more patients involved in clinical trials to move the best treatments forward.
​
The foundation has been set. Help ensure the future of this program by supporting GBM AGILE in Australia.